These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31782880)

  • 1. Association of plasma pentraxin 3 concentration with angiographic and clinical outcomes in patients with acute ST-segment elevation myocardial infarction treated by primary angioplasty.
    Dharma S; Sari NY; Santoso A; Sukmawan R; Rao SV
    Catheter Cardiovasc Interv; 2020 Nov; 96(6):1233-1239. PubMed ID: 31782880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of microRNA-224-3p and microRNA-155-5p expressions with plasma long pentraxin 3 concentration and coronary microvascular obstruction following primary angioplasty for acute ST-segment elevation myocardial infarction.
    Dharma S; Dakota I; Wijaya S; Ekawati E; Sukmawan R; Siswanto BB
    BMC Res Notes; 2020 Oct; 13(1):499. PubMed ID: 33121529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
    Akgul O; Baycan OF; Bulut U; Somuncu MU; Pusuroglu H; Ozyilmaz S; Gul M; Demir AR; Yılmaz E; Yazan S; Kokturk U; Cetin I; Uyarel H
    Coron Artery Dis; 2015 Nov; 26(7):592-7. PubMed ID: 26061437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size.
    Butt N; Bache-Mathiesen LK; Ushakova A; Nordrehaug JE; Jensen SE; Munk PS; Danchin N; Dubois-Rande JL; Hansen HS; Paganelli F; Corvoisier PL; Firat H; Erlinge D; Atar D; Larsen AI
    Eur Heart J Acute Cardiovasc Care; 2020 Jun; 9(4):302-312. PubMed ID: 32403934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
    BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS-AMI (The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial.
    Kosmidou I; McAndrew T; Redfors B; Embacher M; Dizon JM; Mehran R; Ben-Yehuda O; Mintz GS; Stone GW
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of mortality in patients with non-anterior ST-segment elevation myocardial infarction: Analysis from the HORIZONS-AMI trial.
    Huang X; Redfors B; Chen S; Gersh BJ; Mehran R; Zhang Y; McAndrew T; Ben-Yehuda O; Mintz GS; Stone GW
    Catheter Cardiovasc Interv; 2019 Aug; 94(2):172-180. PubMed ID: 30690854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentraxin 3 might be better prognostic serum marker than IL-6, IL-10, and high-sensitivity C-reactive protein for major adverse cardiovascular events in patients with ST-elevation myocardial infarction after bare-metal stent implantation.
    Ljuca F; Hadžiefendić B; Jahić E; Tihić N; Lukić S
    Saudi Med J; 2019 Dec; 40(12):1202-1208. PubMed ID: 31828271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry.
    Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated plasma level of pentraxin-3 predicts in-hospital and 30-day clinical outcomes in patients with non-ST-segment elevation myocardial infarction who have undergone percutaneous coronary intervention.
    Guo R; Li Y; Wen J; Li W; Xu Y
    Cardiology; 2014; 129(3):178-88. PubMed ID: 25323314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twelve-month clinical outcomes of acute non-ST versus ST-segment elevation myocardial infarction patients with reduced preprocedural thrombolysis in myocardial infarction flow undergoing percutaneous coronary intervention.
    Baek JY; Kang TS; Rha SW; Choi BG; Park SH; Jeong MH
    Coron Artery Dis; 2018 Aug; 29(5):416-422. PubMed ID: 29708887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes in men and women with ST-segment elevation myocardial infarction and incomplete reperfusion after a primary percutaneous coronary intervention: a 2-year follow-up.
    Zachura M; Wilczek K; Janion M; Gąsior M; Gierlotka M; Sadowski M
    Coron Artery Dis; 2019 May; 30(3):171-176. PubMed ID: 30973830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Mandurino-Mirizzi A; Cornara S; Somaschini A; Demarchi A; Galazzi M; Puccio S; Montalto C; Crimi G; Ferlini M; Camporotondo R; Gnecchi M; Ferrario M; Oltrona-Visconti L; De Ferrari GM
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):608-614. PubMed ID: 33358717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy.
    Falkentoft AC; Rørth R; Iversen K; Høfsten DE; Kelbæk H; Holmvang L; Frydland M; Schoos MM; Helqvist S; Axelsson A; Clemmensen P; Jørgensen E; Saunamäki K; Tilsted HH; Pedersen F; Torp-Pedersen C; Kofoed KF; Goetze JP; Engstrøm T; Køber L
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29776961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Monocyte Count on Admission with the Angiographic Thrombus Burden in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Wang Z; Liu N; Ren L; Lei L; Ye H; Peng J
    Arq Bras Cardiol; 2018 Apr; 110(4):333-338. PubMed ID: 29538502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of High-Risk Patients After ST-Segment-Elevation Myocardial Infarction: Comparison Between Angiographic and Magnetic Resonance Parameters.
    Durante A; Laricchia A; Benedetti G; Esposito A; Margonato A; Rimoldi O; De Cobelli F; Colombo A; Camici PG
    Circ Cardiovasc Imaging; 2017 Jun; 10(6):e005841. PubMed ID: 28592591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Residual Thrombus After Aspiration Thrombectomy Affect the Outcome of Primary PCI in Patients With ST-Segment Elevation Myocardial Infarction?: An Optical Coherence Tomography Study.
    Higuma T; Soeda T; Yamada M; Yokota T; Yokoyama H; Izumiyama K; Nishizaki F; Minami Y; Xing L; Yamamoto E; Lee H; Okumura K; Jang IK
    JACC Cardiovasc Interv; 2016 Oct; 9(19):2002-2011. PubMed ID: 27712735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Troponin on Presentation and In-Hospital Mortality in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Wanamaker BL; Seth MM; Sukul D; Dixon SR; Bhatt DL; Madder RD; Rumsfeld JS; Gurm HS
    J Am Heart Assoc; 2019 Oct; 8(19):e013551. PubMed ID: 31547767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of angiographic and other findings and mortality in non-ST-segment elevation versus ST-segment elevation myocardial infarction in patients undergoing early invasive intervention.
    Song YB; Hahn JY; Kim JH; Lee SY; Choi SH; Choi JH; Choi SH; Lee SH; Yoon J; Kim YJ; Jeong MH; Gwon HC;
    Am J Cardiol; 2010 Nov; 106(10):1397-403. PubMed ID: 21059427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.